Steroid Premedication Impact on Efficacy and Cutaneous Toxicity of Enfortumab Vedotin for Advanced Urothelial Carcinoma Article Swipe
Nobuki Furubayashi
,
Manabu Mochida
,
Aki Kijima
,
Yo Fujimoto
,
Motonobu Nakamura
,
Takahito Negishi
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.21873/invivo.13961
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.21873/invivo.13961
In EV treatment, steroid premedication did not affect clinical outcomes. The incidence and severity of EV-related cutaneous toxicity tended to improve in patients who received steroid premedication, although no significant differences were observed.
Related Topics
Concepts
Urothelial carcinoma
Premedication
Medicine
Toxicity
Oncology
Internal medicine
Surgery
Cancer
Bladder cancer
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.21873/invivo.13961
- https://iv.iiarjournals.org/content/invivo/39/3/1607.full.pdf
- OA Status
- diamond
- Cited By
- 1
- References
- 13
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4409888453
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4409888453Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.21873/invivo.13961Digital Object Identifier
- Title
-
Steroid Premedication Impact on Efficacy and Cutaneous Toxicity of Enfortumab Vedotin for Advanced Urothelial CarcinomaWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-04-28Full publication date if available
- Authors
-
Nobuki Furubayashi, Manabu Mochida, Aki Kijima, Yo Fujimoto, Motonobu Nakamura, Takahito NegishiList of authors in order
- Landing page
-
https://doi.org/10.21873/invivo.13961Publisher landing page
- PDF URL
-
https://iv.iiarjournals.org/content/invivo/39/3/1607.full.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://iv.iiarjournals.org/content/invivo/39/3/1607.full.pdfDirect OA link when available
- Concepts
-
Urothelial carcinoma, Premedication, Medicine, Toxicity, Oncology, Internal medicine, Surgery, Cancer, Bladder cancerTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
1Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1Per-year citation counts (last 5 years)
- References (count)
-
13Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4409888453 |
|---|---|
| doi | https://doi.org/10.21873/invivo.13961 |
| ids.doi | https://doi.org/10.21873/invivo.13961 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40295014 |
| ids.openalex | https://openalex.org/W4409888453 |
| fwci | 6.62138127 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D008297 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Male |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D000368 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Aged |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D005260 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Female |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D008875 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Middle Aged |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D012189 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Retrospective Studies |
| mesh[6].qualifier_ui | Q000379 |
| mesh[6].descriptor_ui | D011292 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | methods |
| mesh[6].descriptor_name | Premedication |
| mesh[7].qualifier_ui | Q000009 |
| mesh[7].descriptor_ui | D000911 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | adverse effects |
| mesh[7].descriptor_name | Antibodies, Monoclonal |
| mesh[8].qualifier_ui | Q000008 |
| mesh[8].descriptor_ui | D000911 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | administration & dosage |
| mesh[8].descriptor_name | Antibodies, Monoclonal |
| mesh[9].qualifier_ui | Q000627 |
| mesh[9].descriptor_ui | D000911 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | therapeutic use |
| mesh[9].descriptor_name | Antibodies, Monoclonal |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D000369 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Aged, 80 and over |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D016896 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Treatment Outcome |
| mesh[12].qualifier_ui | Q000008 |
| mesh[12].descriptor_ui | D013256 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | administration & dosage |
| mesh[12].descriptor_name | Steroids |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D009367 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Neoplasm Staging |
| mesh[14].qualifier_ui | Q000188 |
| mesh[14].descriptor_ui | D014571 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | drug therapy |
| mesh[14].descriptor_name | Urologic Neoplasms |
| mesh[15].qualifier_ui | Q000473 |
| mesh[15].descriptor_ui | D014571 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | pathology |
| mesh[15].descriptor_name | Urologic Neoplasms |
| mesh[16].qualifier_ui | Q000008 |
| mesh[16].descriptor_ui | D003907 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | administration & dosage |
| mesh[16].descriptor_name | Dexamethasone |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D006801 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Humans |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D008297 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Male |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D000368 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Aged |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D005260 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Female |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D008875 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Middle Aged |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D012189 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Retrospective Studies |
| mesh[23].qualifier_ui | Q000379 |
| mesh[23].descriptor_ui | D011292 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | methods |
| mesh[23].descriptor_name | Premedication |
| mesh[24].qualifier_ui | Q000009 |
| mesh[24].descriptor_ui | D000911 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | adverse effects |
| mesh[24].descriptor_name | Antibodies, Monoclonal |
| mesh[25].qualifier_ui | Q000008 |
| mesh[25].descriptor_ui | D000911 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | administration & dosage |
| mesh[25].descriptor_name | Antibodies, Monoclonal |
| mesh[26].qualifier_ui | Q000627 |
| mesh[26].descriptor_ui | D000911 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | therapeutic use |
| mesh[26].descriptor_name | Antibodies, Monoclonal |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D000369 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Aged, 80 and over |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D016896 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Treatment Outcome |
| mesh[29].qualifier_ui | Q000008 |
| mesh[29].descriptor_ui | D013256 |
| mesh[29].is_major_topic | True |
| mesh[29].qualifier_name | administration & dosage |
| mesh[29].descriptor_name | Steroids |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D009367 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Neoplasm Staging |
| mesh[31].qualifier_ui | Q000188 |
| mesh[31].descriptor_ui | D014571 |
| mesh[31].is_major_topic | True |
| mesh[31].qualifier_name | drug therapy |
| mesh[31].descriptor_name | Urologic Neoplasms |
| mesh[32].qualifier_ui | Q000473 |
| mesh[32].descriptor_ui | D014571 |
| mesh[32].is_major_topic | True |
| mesh[32].qualifier_name | pathology |
| mesh[32].descriptor_name | Urologic Neoplasms |
| mesh[33].qualifier_ui | Q000008 |
| mesh[33].descriptor_ui | D003907 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | administration & dosage |
| mesh[33].descriptor_name | Dexamethasone |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D006801 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Humans |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D008297 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Male |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D000368 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Aged |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D005260 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Female |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D008875 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | Middle Aged |
| mesh[39].qualifier_ui | |
| mesh[39].descriptor_ui | D012189 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | |
| mesh[39].descriptor_name | Retrospective Studies |
| mesh[40].qualifier_ui | Q000379 |
| mesh[40].descriptor_ui | D011292 |
| mesh[40].is_major_topic | True |
| mesh[40].qualifier_name | methods |
| mesh[40].descriptor_name | Premedication |
| mesh[41].qualifier_ui | Q000009 |
| mesh[41].descriptor_ui | D000911 |
| mesh[41].is_major_topic | True |
| mesh[41].qualifier_name | adverse effects |
| mesh[41].descriptor_name | Antibodies, Monoclonal |
| mesh[42].qualifier_ui | Q000008 |
| mesh[42].descriptor_ui | D000911 |
| mesh[42].is_major_topic | True |
| mesh[42].qualifier_name | administration & dosage |
| mesh[42].descriptor_name | Antibodies, Monoclonal |
| mesh[43].qualifier_ui | Q000627 |
| mesh[43].descriptor_ui | D000911 |
| mesh[43].is_major_topic | True |
| mesh[43].qualifier_name | therapeutic use |
| mesh[43].descriptor_name | Antibodies, Monoclonal |
| mesh[44].qualifier_ui | |
| mesh[44].descriptor_ui | D000369 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | |
| mesh[44].descriptor_name | Aged, 80 and over |
| mesh[45].qualifier_ui | |
| mesh[45].descriptor_ui | D016896 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | |
| mesh[45].descriptor_name | Treatment Outcome |
| mesh[46].qualifier_ui | Q000008 |
| mesh[46].descriptor_ui | D013256 |
| mesh[46].is_major_topic | True |
| mesh[46].qualifier_name | administration & dosage |
| mesh[46].descriptor_name | Steroids |
| mesh[47].qualifier_ui | |
| mesh[47].descriptor_ui | D009367 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | |
| mesh[47].descriptor_name | Neoplasm Staging |
| mesh[48].qualifier_ui | Q000188 |
| mesh[48].descriptor_ui | D014571 |
| mesh[48].is_major_topic | True |
| mesh[48].qualifier_name | drug therapy |
| mesh[48].descriptor_name | Urologic Neoplasms |
| mesh[49].qualifier_ui | Q000473 |
| mesh[49].descriptor_ui | D014571 |
| mesh[49].is_major_topic | True |
| mesh[49].qualifier_name | pathology |
| mesh[49].descriptor_name | Urologic Neoplasms |
| type | article |
| title | Steroid Premedication Impact on Efficacy and Cutaneous Toxicity of Enfortumab Vedotin for Advanced Urothelial Carcinoma |
| biblio.issue | 3 |
| biblio.volume | 39 |
| biblio.last_page | 1614 |
| biblio.first_page | 1607 |
| topics[0].id | https://openalex.org/T10458 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9453999996185303 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2746 |
| topics[0].subfield.display_name | Surgery |
| topics[0].display_name | Bladder and Urothelial Cancer Treatments |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C3019882237 |
| concepts[0].level | 4 |
| concepts[0].score | 0.778033971786499 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q2501186 |
| concepts[0].display_name | Urothelial carcinoma |
| concepts[1].id | https://openalex.org/C2778300832 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7285363674163818 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1589604 |
| concepts[1].display_name | Premedication |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.6125822067260742 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C29730261 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5828506946563721 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q274160 |
| concepts[3].display_name | Toxicity |
| concepts[4].id | https://openalex.org/C143998085 |
| concepts[4].level | 1 |
| concepts[4].score | 0.46876662969589233 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[4].display_name | Oncology |
| concepts[5].id | https://openalex.org/C126322002 |
| concepts[5].level | 1 |
| concepts[5].score | 0.4413541555404663 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[5].display_name | Internal medicine |
| concepts[6].id | https://openalex.org/C141071460 |
| concepts[6].level | 1 |
| concepts[6].score | 0.14129984378814697 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q40821 |
| concepts[6].display_name | Surgery |
| concepts[7].id | https://openalex.org/C121608353 |
| concepts[7].level | 2 |
| concepts[7].score | 0.12499609589576721 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[7].display_name | Cancer |
| concepts[8].id | https://openalex.org/C2780352672 |
| concepts[8].level | 3 |
| concepts[8].score | 0.05432003736495972 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q504775 |
| concepts[8].display_name | Bladder cancer |
| keywords[0].id | https://openalex.org/keywords/urothelial-carcinoma |
| keywords[0].score | 0.778033971786499 |
| keywords[0].display_name | Urothelial carcinoma |
| keywords[1].id | https://openalex.org/keywords/premedication |
| keywords[1].score | 0.7285363674163818 |
| keywords[1].display_name | Premedication |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.6125822067260742 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/toxicity |
| keywords[3].score | 0.5828506946563721 |
| keywords[3].display_name | Toxicity |
| keywords[4].id | https://openalex.org/keywords/oncology |
| keywords[4].score | 0.46876662969589233 |
| keywords[4].display_name | Oncology |
| keywords[5].id | https://openalex.org/keywords/internal-medicine |
| keywords[5].score | 0.4413541555404663 |
| keywords[5].display_name | Internal medicine |
| keywords[6].id | https://openalex.org/keywords/surgery |
| keywords[6].score | 0.14129984378814697 |
| keywords[6].display_name | Surgery |
| keywords[7].id | https://openalex.org/keywords/cancer |
| keywords[7].score | 0.12499609589576721 |
| keywords[7].display_name | Cancer |
| keywords[8].id | https://openalex.org/keywords/bladder-cancer |
| keywords[8].score | 0.05432003736495972 |
| keywords[8].display_name | Bladder cancer |
| language | en |
| locations[0].id | doi:10.21873/invivo.13961 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S115443242 |
| locations[0].source.issn | 0258-851X, 1791-7549 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 0258-851X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | In Vivo |
| locations[0].source.host_organization | https://openalex.org/P4322764940 |
| locations[0].source.host_organization_name | Stanford University Highwire Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4322764940 |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | https://iv.iiarjournals.org/content/invivo/39/3/1607.full.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | In Vivo |
| locations[0].landing_page_url | https://doi.org/10.21873/invivo.13961 |
| locations[1].id | pmid:40295014 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | In vivo (Athens, Greece) |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40295014 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:12041992 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | In Vivo |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12041992 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5071222216 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-9159-493X |
| authorships[0].author.display_name | Nobuki Furubayashi |
| authorships[0].countries | JP |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210093709 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Urology, NHO Kyushu Cancer Center, Fukuoka, Japan [email protected]. |
| authorships[0].institutions[0].id | https://openalex.org/I4210093709 |
| authorships[0].institutions[0].ror | https://ror.org/00mce9b34 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210093709, https://openalex.org/I4210137409 |
| authorships[0].institutions[0].country_code | JP |
| authorships[0].institutions[0].display_name | National Hospital Organization Kyushu Cancer Center |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Nobuki Furubayashi |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Urology, NHO Kyushu Cancer Center, Fukuoka, Japan [email protected]. |
| authorships[1].author.id | https://openalex.org/A5001206415 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Manabu Mochida |
| authorships[1].countries | JP |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210093709 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Urology, NHO Kyushu Cancer Center, Fukuoka, Japan. |
| authorships[1].institutions[0].id | https://openalex.org/I4210093709 |
| authorships[1].institutions[0].ror | https://ror.org/00mce9b34 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210093709, https://openalex.org/I4210137409 |
| authorships[1].institutions[0].country_code | JP |
| authorships[1].institutions[0].display_name | National Hospital Organization Kyushu Cancer Center |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Manabu Mochida |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Urology, NHO Kyushu Cancer Center, Fukuoka, Japan. |
| authorships[2].author.id | https://openalex.org/A5069815128 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Aki Kijima |
| authorships[2].countries | JP |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210093709 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Urology, NHO Kyushu Cancer Center, Fukuoka, Japan. |
| authorships[2].institutions[0].id | https://openalex.org/I4210093709 |
| authorships[2].institutions[0].ror | https://ror.org/00mce9b34 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210093709, https://openalex.org/I4210137409 |
| authorships[2].institutions[0].country_code | JP |
| authorships[2].institutions[0].display_name | National Hospital Organization Kyushu Cancer Center |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Atsuhiro Kijima |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Urology, NHO Kyushu Cancer Center, Fukuoka, Japan. |
| authorships[3].author.id | https://openalex.org/A5112676596 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Yo Fujimoto |
| authorships[3].countries | JP |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210093709 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Urology, NHO Kyushu Cancer Center, Fukuoka, Japan. |
| authorships[3].institutions[0].id | https://openalex.org/I4210093709 |
| authorships[3].institutions[0].ror | https://ror.org/00mce9b34 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210093709, https://openalex.org/I4210137409 |
| authorships[3].institutions[0].country_code | JP |
| authorships[3].institutions[0].display_name | National Hospital Organization Kyushu Cancer Center |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Yushi Fujimoto |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Urology, NHO Kyushu Cancer Center, Fukuoka, Japan. |
| authorships[4].author.id | https://openalex.org/A5102955473 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-3038-1361 |
| authorships[4].author.display_name | Motonobu Nakamura |
| authorships[4].countries | JP |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210093709 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Urology, NHO Kyushu Cancer Center, Fukuoka, Japan. |
| authorships[4].institutions[0].id | https://openalex.org/I4210093709 |
| authorships[4].institutions[0].ror | https://ror.org/00mce9b34 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210093709, https://openalex.org/I4210137409 |
| authorships[4].institutions[0].country_code | JP |
| authorships[4].institutions[0].display_name | National Hospital Organization Kyushu Cancer Center |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Motonobu Nakamura |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Urology, NHO Kyushu Cancer Center, Fukuoka, Japan. |
| authorships[5].author.id | https://openalex.org/A5012284662 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-6645-8829 |
| authorships[5].author.display_name | Takahito Negishi |
| authorships[5].countries | JP |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210093709 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Urology, NHO Kyushu Cancer Center, Fukuoka, Japan. |
| authorships[5].institutions[0].id | https://openalex.org/I4210093709 |
| authorships[5].institutions[0].ror | https://ror.org/00mce9b34 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210093709, https://openalex.org/I4210137409 |
| authorships[5].institutions[0].country_code | JP |
| authorships[5].institutions[0].display_name | National Hospital Organization Kyushu Cancer Center |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | Takahito Negishi |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Urology, NHO Kyushu Cancer Center, Fukuoka, Japan. |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://iv.iiarjournals.org/content/invivo/39/3/1607.full.pdf |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Steroid Premedication Impact on Efficacy and Cutaneous Toxicity of Enfortumab Vedotin for Advanced Urothelial Carcinoma |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10458 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9453999996185303 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2746 |
| primary_topic.subfield.display_name | Surgery |
| primary_topic.display_name | Bladder and Urothelial Cancer Treatments |
| related_works | https://openalex.org/W2471790567, https://openalex.org/W2129397417, https://openalex.org/W2899360650, https://openalex.org/W2360084237, https://openalex.org/W2415550183, https://openalex.org/W2171394439, https://openalex.org/W2364206465, https://openalex.org/W4285012092, https://openalex.org/W2160522866, https://openalex.org/W2412541407 |
| cited_by_count | 1 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | doi:10.21873/invivo.13961 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S115443242 |
| best_oa_location.source.issn | 0258-851X, 1791-7549 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 0258-851X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | In Vivo |
| best_oa_location.source.host_organization | https://openalex.org/P4322764940 |
| best_oa_location.source.host_organization_name | Stanford University Highwire Press |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4322764940 |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | https://iv.iiarjournals.org/content/invivo/39/3/1607.full.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | In Vivo |
| best_oa_location.landing_page_url | https://doi.org/10.21873/invivo.13961 |
| primary_location.id | doi:10.21873/invivo.13961 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S115443242 |
| primary_location.source.issn | 0258-851X, 1791-7549 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 0258-851X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | In Vivo |
| primary_location.source.host_organization | https://openalex.org/P4322764940 |
| primary_location.source.host_organization_name | Stanford University Highwire Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4322764940 |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | https://iv.iiarjournals.org/content/invivo/39/3/1607.full.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | In Vivo |
| primary_location.landing_page_url | https://doi.org/10.21873/invivo.13961 |
| publication_date | 2025-04-28 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W2302699227, https://openalex.org/W4386283669, https://openalex.org/W3127912627, https://openalex.org/W4313333351, https://openalex.org/W2966500633, https://openalex.org/W4207057365, https://openalex.org/W2019607817, https://openalex.org/W2121960517, https://openalex.org/W4400043003, https://openalex.org/W2888599070, https://openalex.org/W3118904262, https://openalex.org/W4381889776, https://openalex.org/W4395001085 |
| referenced_works_count | 13 |
| abstract_inverted_index.EV | 1 |
| abstract_inverted_index.In | 0 |
| abstract_inverted_index.in | 21 |
| abstract_inverted_index.no | 28 |
| abstract_inverted_index.of | 14 |
| abstract_inverted_index.to | 19 |
| abstract_inverted_index.The | 10 |
| abstract_inverted_index.and | 12 |
| abstract_inverted_index.did | 5 |
| abstract_inverted_index.not | 6 |
| abstract_inverted_index.who | 23 |
| abstract_inverted_index.were | 31 |
| abstract_inverted_index.affect | 7 |
| abstract_inverted_index.tended | 18 |
| abstract_inverted_index.improve | 20 |
| abstract_inverted_index.steroid | 3, 25 |
| abstract_inverted_index.although | 27 |
| abstract_inverted_index.clinical | 8 |
| abstract_inverted_index.patients | 22 |
| abstract_inverted_index.received | 24 |
| abstract_inverted_index.severity | 13 |
| abstract_inverted_index.toxicity | 17 |
| abstract_inverted_index.cutaneous | 16 |
| abstract_inverted_index.incidence | 11 |
| abstract_inverted_index.observed. | 32 |
| abstract_inverted_index.outcomes. | 9 |
| abstract_inverted_index.EV-related | 15 |
| abstract_inverted_index.treatment, | 2 |
| abstract_inverted_index.differences | 30 |
| abstract_inverted_index.significant | 29 |
| abstract_inverted_index.premedication | 4 |
| abstract_inverted_index.premedication, | 26 |
| cited_by_percentile_year.max | 95 |
| cited_by_percentile_year.min | 91 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 6 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/2 |
| sustainable_development_goals[0].score | 0.5400000214576721 |
| sustainable_development_goals[0].display_name | Zero hunger |
| citation_normalized_percentile.value | 0.89332675 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |